James Kehoe - Walgreens Boots Global CFO, Executive Vice President - Global

<div class='circular--portrait' style='background:#347AFC;color: #ffffff;font-size:4em;padding-top: 25px;;'>WB</div>
WBA -- USA Stock  

Report: 25th of June 2020  

  President
Mr. James Kehoe is Global Chief Financial Officer, Executive Vice President of the Company. Kehoe was chief financial officer of Takeda Pharmaceutical since June 2016 and was based in Tokyo, reporting directly to the company president and CEO. He was appointed to the Takeda Pharmaceutical board of directors in June 2017. Kehoe is an accomplished finance executive from the consumer goods sector and a strong business leader with a track record of driving operational business performance. He joined Takeda Pharmaceutical from Kraft Foods Group in the U.S., where he last held the role of executive vice president, chief financial officer. Prior to that, he held a number of financerelated positions over 25 years with assignments based in Ireland, Germany, Italy, U.S., Austria, Switzerland and Canada.
Age: 54  President Since 2019      
847 315-2500  www.walgreensbootsalliance.com

James Kehoe Latest Insider Activity

Walgreens Boots Management Efficiency

Walgreens Boots Alli has Return on Asset of 0.0732 % which means that on every $100 spent on asset it made $0.0732 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 0.1417 % implying that it generated $0.1417 on every 100 dollars invested. Walgreens Boots management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Walgreens Boots Return on Investment is expected to slightly decrease based on the last few years of reporting. The last year's Return on Investment was at 10.78. The current year Return on Invested Capital is expected to grow to 0.23, whereas Return on Average Assets are expected to decline to 0.0007. Walgreens Boots Total Assets are expected to significantly increase based on the last few years of reporting. The last year's Total Assets were at 60.84 Billion. The current year Current Assets is expected to grow to about 25.9 B, whereas Revenue to Assets are expected to decline to 1.73. Walgreens Boots Liabilities Non Current is expected to significantly increase based on the last few years of reporting. The last year's Liabilities Non Current was at 22.85 Billion. The current year Tax Liabilities is expected to grow to about 2.8 B, whereas Total Liabilities is expected to decline to about 36.6 B.
The company has 17.93 B in debt with debt to equity (D/E) ratio of 74.2 . This implies that the company may be unable to create cash to meet all of its financial commitments. Walgreens Boots Alli has Current Ratio of 0.72 suggesting that it has not enough short term capital to pay financial commitments when the payables are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Brently BaxterSally Beauty Holdings
2018
Michael McNamaraTarget
2019
Douglas MartinSpectrum Brands Holdings
2018
Rebeckah LongSpectrum Brands Holdings
2019
Anne DamentTarget
2015
Enio MontiniRite Aid
N/A
Ajoy KarnaSysco
2017
Rick GomezTarget
2019
Arthur ValdezTarget
2016
Jeffrey JonesTarget
N/A
Jacqueline RiceTarget
2014
Ehsan ZargarSpectrum Brands Holdings
2018
Jason GoldbergerTarget
2016
Theodore FrumkinSprouts Farmers Market
2015
Kermit CrawfordRite Aid
2017
Don LiuTarget
2017
David AbelmanRite Aid
2015
Casey CarlTarget
2014
Heather PlutinoSally Beauty Holdings
2019
Robert HarrisonTarget
2015
Joel GradeSysco
2015

Company Summary

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois. Walgreens Boots operates under Pharmaceutical Retailers classification in USA and is traded on BATS Exchange. It employs 232000 people.Walgreens Boots Alliance (WBA) is traded on BATS Exchange in USA and employs 232,000 people.

Walgreens Boots Alli Leadership Team

Alexander Gourlay, Executive VP and President of Walgreens Co
James Skinner, Executive Chairman
David Brailer, Independent Director
Leonard Schaeffer, Independent Director
Nancy Schlichting, Independent Director
Dominic Murphy, Director
Jan Reed, Senior Vice President General Counsel, Corporatye Secretary
James Kehoe, Global CFO, Executive Vice President - Global
Anthony Roberts, Senior Vice President Global CIO
Marco Pagni, Executive Vice President Global Chief Legal and Administrative Officer
John Lederer, Director
Ken Murphy, Executive Vice President of Walgreens Boots Alliance and Presidentident of Global Brands
Stefano Pessina, Executive Vice Chairman and CEO
Simon Roberts, Executive Vice President of Walgreens Boots Alliance and President of Boots
Gerald Gradwell, IR Contact Officer
Heather Dixon, Senior Vice President Chief Accounting Officer, Global Controller
Kimberly Scardino, Senior Vice President Chief Accounting Officer, Global Controller
Kathleen WilsonThompson, Executive Vice President Global Chief Human Resources Officer
Jeffrey Berkowitz, Executive Vice President of Walgreens Boots Alliance and Presidentident of Pharma and Global Market Access
Ornella Barra, Executive Vice President of Walgreens Boots Alliance and Presidentident and Chief Executive of Global Wholesale and International Retail
Barry Rosenstein, Independent Director
Jose Almeida, Director
Janice Babiak, Independent Director
William Foote, Lead Independent Director
Ginger Graham, Independent Director
George Fairweather, Global CFO and Executive VP

Stock Performance Indicators

Current Sentiment - WBA

Walgreens Boots Alli Investor Sentiment

Greater number of Macroaxis users are at this time bullish on Walgreens Boots Alliance. What is your outlook on investing in Walgreens Boots Alliance? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Also Currentnly Active

<div class='circular--portrait-small' style='font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:1.1em;padding-top: 10px;;'>AL</div>
Purchased few shares of
1 hour ago
Traded for 1412.1801
<div class='circular--portrait-small' style='font-weight: 700;background:#754DEB;color: #F0FFF0;font-size:1.1em;padding-top: 10px;;'>MI</div>
Purchased few shares of
1 hour ago
Traded for 182.92
<div class='circular--portrait-small' style='font-weight: 700;background:#4E8BFC;color: #ffffff;font-size:1.1em;padding-top: 10px;;'>SA</div>
Purchased few shares of
1 hour ago
Traded for 171.44
Check out Your Current Watchlist. Please also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page